Metástasis en clivus de hepatocarcinoma asociado a quimiembolización transarterial hepática

Escarda, Ana; Vaquer, Pere; Bonet, Lucía; Miralbés, Salvador; Gómez, Cristina; Obrador, Antoni.
Gastroenterol. hepatol. (Ed. impr.) ; 29(7): 401-405, ago. 2006. ilus
Artículo en Es | IBECS (España) | ID: ibc-046913

Documentos relacionados

  1. Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems.
  2. Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy.
  3. Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-Staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study.
  4. Idarubicin versus epirubicin in drug-eluting beads-transarterial chemoembolization for treating hepatocellular carcinoma: A real-world retrospective study.
  5. Cisplatin in Liver Cancer Therapy.
  6. Efficacy of treatment based on TKIs in combination with PD-1 inhibitors for unresectable recurrent hepatocellular carcinoma.
  7. TACE with dicycloplatin in patients with unresectable hepatocellular carcinoma: a multicenter randomized phase II trial.
  8. Ameliorative Effect of <i>Posidonia oceanica</i> on High Glucose-Related Stress in Human Hepatoma HepG2 Cells.
  9. Iron Oxide Nanoparticles Functionalized with Fucoidan: a Potential Theranostic Nanotool for Hepatocellular Carcinoma.
  10. ROS in hepatocellular carcinoma: What we know.